[EN] PHTHALAZINE DERIVATIVES AS INHIBITORS OF PARP1, PARP2 AND/OR TUBULIN USEFUL FOR THE TREATMENT OF CANCER<br/>[FR] DÉRIVÉS DE PHTALAZINE UTILES EN TANT QU'INHIBITEURS DE PARP1, PARP2 ET/OU DE TUBULINE DANS LE TRAITEMENT DU CANCER
申请人:UNIV CALIFORNIA
公开号:WO2017223516A1
公开(公告)日:2017-12-28
The application relates to phthalazine derivatives of formula (I) which are inhibitors of PARP1, PARP2 and/or tubulin and thus useful for the treatment of cancer. Also disclosed are pharmaceutical formulations containing such compounds, as well as combinations of these compounds with at least one additional therapeutic agent.
A Serendipitous One‐Pot Cyanation/Hydrolysis/Enamide Formation: Direct Access to 3‐Methyleneisoindolin‐1‐ones
作者:Trisha Banik、Krishna P. Kaliappan
DOI:10.1002/chem.202003209
日期:2021.1.7
A direct, one‐pot conversion of 2’‐haloacetophenones to 3‐methyleneisoindolin‐1‐one scaffolds using CuCN as the sole reagent without the need for moisture‐free or anaerobic conditions is reported. This serendipitously discovered transformation with a broad substrate scope provides a significantly different route towards these important scaffolds. The scope of the method has also been further extended
prepared from o-haloacetophenone derivatives 15 by palladium-catalyzed carbonylation, react with the titaniumisocyanate complex [3THF·Mg2Cl2OTiNCO] (1) generated by fixation of CO2 with titaniumnitrogen complex [TiNMg2Cl2·THF] to give the isoindolinone derivatives 8 in good yields.
The development of an unprecedented methodology based upon direct photolysis of N,N-disubstituted hydrazides to secure N-N bondcleavage and to trigger the formation of NH-free lactams has been disclosed.
已经公开了基于 N,N-二取代酰肼的直接光解以确保 NN 键断裂并触发无 NH 内酰胺的形成的前所未有的方法的开发。